Viewing Study NCT01258868


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-29 @ 11:53 AM
Study NCT ID: NCT01258868
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2010-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module